Volume 197 - Issue 3

Headache sufferers need to be heard too

Author:  Alessandro S Zagami

Med J Aust 2012; 197 (3): 146. || doi: 10.5694/mja12.10910
Published online: 6 August 2012
To the Editor: The 2 April issue of the Journal contained several articles on pain, but no mention of patients who suffer with head pain. Headache is one of the commonest acute and chronic pain conditions. Studies have shown that episodic migraine affects 18% of women and 8% of men.1 Daily headache afflicts 4% of people worldwide, and half have chronic migraine.2 According to data from ...

To the Editor: The 2 April issue of the Journal contained several articles on pain, but no mention of patients who suffer with head pain. Headache is one of the commonest acute and chronic pain conditions. Studies have shown that episodic migraine affects 18% of women and 8% of men.1 Daily headache afflicts 4% of people worldwide, and half have chronic migraine.2 According to data from the World Health Organization, migraine ranks eighth in the global burden of disability resulting from mental, neurological and substance-use disorders.3

Thus, headache and migraine are major problems. The Atlas of headache disorders and resources in the world 2011 states that “Headache disorders are ubiquitous, prevalent and disabling. Yet they are under-recognized, under-diagnosed and under-treated”.4 It identifies barriers to care and critical changes that are needed, including better education and availability of headache services.

The situation in Australia is no different. Based on the results of the 2011 Merck, Sharp and Dohme migraine survey commissioned by Headache Australia, 33% of people who have migraines experienced them every 2 weeks or more frequently; 42% experienced attacks lasting a full day, 81% are seeking better treatment, and 21.7 days were “lost to migraine” annually.5 In terms of the profile of headache in the pain management community, it is disappointing that migraine is barely mentioned in the 2010 National pain strategy.6

Recently, there has been a long overdue increase worldwide in experimental and clinical research into headache, and there have been major advances in the treatment of migraine. Thus at present, there is a huge unmet need, as well as potential new treatments that are, or soon will be, available to headache sufferers. It is time that their voice was heard too.


Author


Competing interests


References


More like this

Neurology Perspective 3 November 2025 Free

Mild traumatic brain injury and concussion and persisting post‐concussion symptoms: new guidelines to support evidence‐based assessment and management in Australia and Aotearoa New Zealand

Karen M Barlow, Jennie L Ponsford, Alice Theodom, Gill Cowen, Gavin A Davis, Vicki Anderson, Franz E Babl, David Cole, Jennifer Cullen, Stuart R Dalziel, Melinda Fitzgerald, Howard Flavell, Caroline Yates, Rebecca Kimble, John H Olver, Rhonda Orr, Mark Ralfe, Michael Rose, Nick Rushworth, Julia Treleaven, Gary Browne, Nathan Delang, Sarah Harris, Gary Mitchell, Sean Tweedy

Neurology Research 4 August 2025 Open Access

The prevalence of and variation in indicators of the quality and safety of long term aged care in Australia, 2019: a cross‐sectional population‐based study

Tesfahun C Eshetie, Gillian E Caughey, Catherine Lang, Olivia Ryan, Renuka Visvanathan, Craig Whitehead, Keith Evans, Janet K Sluggett, Jyoti Khadka, Carolyn Dawkins, Helena Williams, Miranda Starke, Sara Blunt, Anne Liddell, Megan Corlis, Anna Sheppeard, Penelope Lello, Marilyn Thien, Steven L Wesselingh, Maria C Inacio